Literature DB >> 32389258

The Ever-Changing World of Limb Salvage Surgery for Malignant Bone Tumors.

Kimberly K Haynes1, Howard G Rosenthal2.   

Abstract

The treatment of malignant bone tumors, also called bone sarcomas, has changed dramatically over the past 50 years owing to the advances in chemotherapy, immunotherapy, targeted therapy, radiation, prosthetic technology, and surgical advances. There are 3 main primary bone cancers: osteosarcoma, Ewing's sarcoma (or Ewing's family of sarcoma), and chondrosarcoma. Before advances in limb preservation techniques and before the development of prosthetic replacement, the treatment for a malignant bone tumor of the extremity was amputation. This article discusses the progression of surgical treatment of malignant bone cancers.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone sarcomas; Chondrosarcoma; Ewing sarcoma; Limb salvage surgery; Limb-sparing surgery; Osteosarcoma

Year:  2020        PMID: 32389258     DOI: 10.1016/j.cnur.2020.02.006

Source DB:  PubMed          Journal:  Nurs Clin North Am        ISSN: 0029-6465            Impact factor:   1.208


  4 in total

1.  Experience with periprosthetic infection after limb salvage surgery for patients with osteosarcoma.

Authors:  Tiao Lin; Qinglin Jin; Xiaolin Mo; Zhiqiang Zhao; Xianbiao Xie; Changye Zou; Gang Huang; Junqiang Yin; Jingnan Shen
Journal:  J Orthop Surg Res       Date:  2021-01-28       Impact factor: 2.677

2.  Efficacy of Neoadjuvant Chemotherapy plus Limb-Sparing Surgery for Osteosarcoma and Its Impact on Long-Term Quality of Life.

Authors:  Shixia Jing; Fengling Ding; Yinghong Yuan; Jing An; Qiang He
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-08       Impact factor: 2.650

Review 3.  Current Status and Prospects of Clinical Treatment of Osteosarcoma.

Authors:  Zong-Yuan Jiang; Ji-Bin Liu; Xiao-Feng Wang; Yu-Shui Ma; Da Fu
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

4.  Plastic lengthening amputation with vascularized bone grafts in children with bone sarcoma: a preliminary report.

Authors:  Zhiqiang Zhao; Qinglin Jin; Xianbiao Xie; Yongqian Wang; Tiao Lin; Junqiang Yin; Gang Huang; Changye Zou; Jingnan Shen
Journal:  World J Surg Oncol       Date:  2020-09-15       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.